Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Dr Lal Pathlabs LtdIndustry : Healthcare
BSE Code:539524NSE Symbol: LALPATHLABP/E(TTM):50.39
ISIN Demat:INE600L01024Div & Yield %:0.8EPS(TTM):59.55
Book Value(Rs):254.778098Market Cap ( Cr.):25138.94Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 2351.621966.761769.031878.791490.561273.60
Excise Duty0.000.000.000.000.000.00
Net Sales2351.621966.761769.031878.791490.561273.60
Other Income 111.5260.1146.6053.1051.2757.61
Stock Adjustments 0.000.000.000.000.000.00
Total Income2463.142026.871815.631931.891541.831331.21
EXPENDITURE :      
Raw Materials 455.24390.76389.64447.65373.90286.87
Power & Fuel Cost25.4821.5421.3119.6617.1815.65
Employee Cost 457.54363.59315.50321.44257.44232.07
Other Manufacturing Expenses 438.81376.33344.15336.38243.96212.40
Selling and Administration Expenses 261.40209.38196.57196.04152.52161.60
Miscellaneous Expenses 47.7545.9341.1745.1638.1837.20
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1686.211407.521308.331366.321083.18945.79
Operating Profit776.93619.35507.30565.57458.65385.42
Interest 21.5026.8434.3828.6314.8314.66
Gross Profit755.43592.51472.92536.94443.82370.76
Depreciation134.1576.5482.0975.9469.7868.01
Profit Before Tax621.28515.97390.83461.00374.04302.75
Tax163.34137.58101.44118.4298.4380.25
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-39.32-5.98-2.97-2.68-4.49-0.67
Reported Net Profit497.26384.37292.36345.25280.11223.18
Extraordinary Items -1.590.241.110.20-0.130.11
Adjusted Net Profit498.85384.13291.25345.05280.24223.07
Adjst. below Net Profit -3.90-0.271.94-1.32-0.71-6.72
P & L Balance brought forward1528.751378.661183.79955.56773.56704.92
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 199.91199.4899.43115.7199.11147.82
P & L Balance carried down1822.201563.281378.661183.79953.84773.56
Dividend149.97149.6549.72115.7199.1198.93
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %240.00240.00120.00120.00200.00120.00
Earnings Per Share-Unit Curr59.4946.0435.0741.4233.6126.78
Earnings Per Share(Adj)-Unit Curr59.4946.0435.0741.4233.6126.78
Book Value-Unit Curr255.32227.56202.70176.63146.03124.83